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Abstract. Previous reports have suggested that Leish-
mania spp. interact with macrophages by binding to
Mac-1 (CDllb/CDl8), a member of the leukocyte in-
tegrin family. To better define this interaction, we
tested the ability of leishmania promastigotes to bind
to purified leukocyte integrins and to cloned integrins
expressed in COS cells. We show that leishmania pro-
mastigotes bind to cellular or purified Mac-1 but not
lymphocyte function-associated antigen-1 in a specific,
dose-dependent manner that requires the presence of
serum. Binding is inhibited with specific monoclonal
antibodies to Mac-1. In the absence of complement
T
HE integrins comprise a family of structurally related
cell surface receptors that coordinate a network of
cell-cell and cell-extracellular matrix interactions
(Springer, 1990; Hemler, 1990) . Lymphocyte function-
associated antigen-1 (LFA-1; l CDl la/CD18), Mac-1 (com-
plement receptor type 3 [CR3] ; CDllb/CD18), and p150,95
(CDllc/CD18) constitute a subfamily of integrins known as
the leukocyte integrins (Kishimoto et al., 1989). These re-
lated glycoproteins, which are critical for the adhesive events
in the immune system, structurally share a common ß sub-
unit that is noncovalently associated with unique a chains .
LFA1, which is expressed on all leukocytes, mediates
lymphocyte adhesion to endothelial cells (Dustin and
Springer, 1989), facilitates the T cell conjugation that is re-
quired for antigen-specific killer and helper functions (Da-
vignon et al., 1981), and promotes the adhesion required for
natural killing (Krensky et al., 1983) . These adhesive inter-
actions occur via at least two characterized counter recep-
tors, ICAM-1 (Rothlein et al ., 1986; Marlin and Springer,
1987) and ICAM-2 (Staunton et al., 1989 ; de Fougerolles
et al ., 1991) . p150,95 is restricted in distribution to myeloid
cells and a small population of T and B lymphocytes. Its
function is not clear, but previous studies have suggested its
1. Abbreviations used in this paper: C3, third component of complement;
C8D, serum from an individual genetically deficient in the eighth compo-
nent ofcomplement; CR3, complement receptor type3; LFA-1, lymphocyte
function-associated antigen-1; LPG, lipophosphoglycan.
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opsonization, three different species of leishmania
tested fail to bind directly to any of the three leuko-
cyte integrins. We show that binding to Mac-1 requires
the third component of complement (C3) . Organisms
incubated in heat-inactivated serum or serum that has
been immunologically depleted of C3 fail to bind to
Mac-1. Because the addition of purified C3 to C3-
depleted serum restores leishmania binding to Mac-1,
we suggest that parasites gain entry into macrophages
by fixing complement and subverting a well-character-
ized adhesive interaction in the immune system between
Mac-1 and iC3b.
involvement in the binding of iC3b-opsonized particles (My-
ones et al., 1988), in the adhesion of cells to endothelium
(Keizer et al., 1987a,b; to Velde et al., 1987), and in cellular
adhesion to substrates coated with serum proteins (Ander-
son et al., 1986; Loike et al., 1991) . Mac-1 is primarily ex-
pressed on myeloid and natural killer cells, and is responsi-
ble for myeloid cell adhesion to endothelial cells, neutrophil
homotypic aggregation, and macrophage phagocytosis of
foreign particles that are opsonized by complement (Kishi-
moto et al., 1989) . Mac-1 achieves these functions by bind-
ing to a multiplicity of cellular and soluble ligands, including
ICAM-1 (Smith et al., 1989; Diamond et al., 1990), iC3b
(Beller et al ., 1982; Wright et al ., 1983), fibrinogen (Altieri
et al., 1988, Wright et al., 1988), and factor X (Altieri and
Edgington, 1988) .
Recently, several groups have reported that leukocyte ad-
hesion receptors on macrophages can mediate the direct
recognition ofmicrobes in the absence ofexogenous comple-
ment. Monoclonal antibodies to one or a combination ofthe
leukocyte integrins have been shown to inhibit the phagocy-
tosis of a diverse array of unopsonized microbial pathogens.
These include Leishmania major (Mosser and Edelson,
1985; DaSilva et al., 1989; Cooper et al ., 1988), Leish-
mania donovani (Blackwell et al., 1985), Leishmania mexi-
cana (Talamus-Rohana et al., 1990), Bordatella pertussis
(Relman et al., 1990), Histoplasma capsulatum (Bullock
and Wright, 1987), Saccharomyces cermisia (Ross et al.,
1985 ; Tàmato et al., 1989), Escherichia coli (Wright andJong, 1986), andMycobacterialeprue (Schlesinger and Hor-
witz, 1990). In some of these studies, macrophages bound
directly to these organisms in vitro in the absence of exog-
enous complement, and this binding was inhibited with anti-
bodies to the CD18 family ofadhesion receptors. The mech-
anism(s) for this direct recognition remains unclear. Mac-1
has been implicated in the binding of saccharides (Ross et
al ., 1985) and polysaccharides (Wright and Jong, 1986)
which may be present on the surface of various microbes.
Mac-1 is also reported to bind directly to two leishmaniasur-
face structures, the lipophosphoglycans (Tàlamus-Rohana et
al ., 1990) and the major surface protease gp63 (Russell and
Wright, 1988). In contrast, others (Ezekowitz et al., 1985 ;
Blackwell et al., 1985) have argued that the recognition of
microbes by Mac-1 depends on C3, which may be derived
from the macrophage itself. To address whether the leuko-
cyte integrins bind directly to endogenous parasite surface
structures, or indirectly via complement components, we
have investigated the binding of leishmania to transfected
fibroblasts expressing leukocyte integrins and to purified leu-
kocyte integrin substrates. In this work we show that the hu-
man leukocyte integrins do not support leishmania binding
directly, but rather require opsonic complement. Further-
more, we show thatwhen complementis present onL. major,
thebinding ofthese organisms is mediated almost exclusively
by the Mac-1 integrin .
Materials andMethods
Leishmania
The U.S. National Institutes of Health S strain of L. major (Bjorvatn and
Neva, 1979) was isolated from a West African patient with cutaneous leish-
maniasis and was originally provided by Dr. D. Wyler, Tufts University
Medical Center (Boston, MA). The Josefastrain ofL. mexicana amazonen-
sis (Mosser et al ., 1986) was isolated from a Brazilian patient with persis-
tent cutaneous leishmaniasis and was provided by Dr. Janet Keithly, New
York State Public Health Center (Albany, NY). The 1S strain ofL. donovani
(Murray, 1981) was isolated from a Sudanese patient with kala azar and was
provided by Dr. Henry Murray, Cornell Medical School, New York. Pro-
mastigotes were cultured in Schneider's complete drosophila mediumto sta-
tionary phaseas described (Mosser et al., 1986) and radiolabeled with triti-
ated uracil overnight as described (Mosser and Edelson, 1985).
MonoclonalAntibodies
The following murine monoclonal antibodies (mAbs) were used diluted
from ascites: LPM19c (IgG2a, anti-CDllb, a gift of Dr. K. Pohlford, Ox-
ford, England) (Uciechowski and Schmidt, 1989), 1413611.2 (IgGI, anti-
CD1lb, a gift ofDr. L. K. Ashman, Adelaide, Australia) (Uciechowski and
Schmidt, 1989), 904 (IgGI, anti-CDllb, a gift of Dr. J. Griffin, Boston,
MA) (Letvin et al., 1983), and TSl/22 (IgGI, anti-CD1la) (Sanchez-Madrid
et al., 1982). The following mAbs were used as purified IgG: R6.5 (IgG2a,
anti-CD54, a gift of Dr. R. Rothlein, Boehringer-Ingelheim, Ridgefield,
CT), YZ.1 (IgGI, anti-CRI, a gift ofDr. R. Jack, Boston, MA) (Changelian
et al., 1985), LM2/1 (IgGI, anti-CDllb) (Miller et al., 1986), 60.3 (IgG2a,
anti-CD18) (Beatty etal., 1983), OKMI (IgG2a, anti-CDIlb) (Wright etal .,
1983), IB4 (IgG2a, anti-CD18) (Wright et al., 1983), and SHCL3 (IgG2b,
anti-CDllc) (Schwarting et al., 1985).
Monocyte-derived Human Macrophages
Monocytes were isolated from peripheral blood using "Lymphoprep"
(Nycomed Pharma, Oslo, Norway) according to themanufacturer's instruc-
tions. They were incubated in RPMI 1640 supplemented with penicillin
G/streptomycin (100 U/ml and 100 pg/ml, respectively), 2 mM glutamine,
and 5% autologous human serum, in Teflon beakers for 4 d as described
(Speert etal., 1988). Cells wereadhered to 13-mmroundcoverglassesover-
night in the presence of 5 % autologous serum, washed the following day
inserum-freephagocytosisbuffer, andused inthe leishmania-binding assay.
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Integrin-coatedSubstrates
Human leukocyte integrins were purified as previously described (Diamond
et al., 1990; Dustin and Springer, 1989; Slacker and Springer, 1991).
Briefly, peripheral blood leukocyte lysates or hairy cell leukemia spleno-
cytes were solubilized in Triton X-100 and the integrins were purified by
immunoaffinity chromatography. Peak fractions ofimmunoaffinity-purified
LFA-1, Mac-1, and p150, 95 protein ata starting concentration of 3-5 pg/ml
in 1% octyl glucoside were diluted 1:12 in 50 mM Tris-HCI, pH 8.0, 150
mM NaCl, 2 mM MgCl, and added to nontissue culture-treated 96-well
plates (Flow Laboratories, Inc., McLean, VA) for 90 min at room tempera-
ture. Plates were subsequently blocked in PBS, 2 mM MgCIZ, 1% BSA for
1 h at 37°C and stored at 4°C until further use in the presence of 0.025 %
NaN3 and 50 14g/ml gentamicin.
Leishmania-binding Assay
Radiolabeled leishmania promastigotes were resuspended in phagocytosis
buffer which consists of equal parts of DME and TC199 buffered with 25
mM Hepes supplemented with 1% BSA. Parasites were added to either
purified integrins on 96-well plates or to macrophages or transfected COS
cells on 24-well plates for60 min at 37°C. For assays performed in the pres-
ence of serum, a final concentration of 5 % serum from a patient with a
deficiency in the eighth componentofcomplement, C8D (Mosser and Edel-
son, 1987), was added to 5 x 107 parasites for 15 min before their addition
to cells orto Mac-l-coated substrates. C8D was used to avoid experimental
artifacts due to complement-mediated lysis, whichcauses the release of free
uracil from radiolabeled parasites (Mosser and Edelson, 1984b). After a
1-h incubation with radiolabeled parasites, plates were washed extensively
using a25-gauge needle aspiration aparatuswith warm (35°C) phagocytosis
buffer. Bound parasites were solubilized in 0.5% Triton X-100 and 0.1 M
NaOH. After neutralization with 0.1 M HCI, lysates were analyzed in
a tri-carb scintillation counter (Packard Instrument Co. Inc., Downers
Grove, IL).
To inhibit parasite binding to Mac-1 plates, purified lipophosphoglycan
(LPG) from L. major was added to Mac-1 plates at a final concentration
of 100 jg/ml for 15 min before and during the addition of leishmania. To
inhibit leishmania C3 opsonization, increasing concentrations ofLPG were
added to a total of 1 x 101 promastigotes in 5 % C8D for 15 min. LPG
(McConville et al ., 1987) was a gift of Emanuela Handman (Melbourne,
Australia).
COS Cell Tlransfections
COScells were transfected in 10-cm tissueculture-treated plates with CDll
and CD18 cDNA as previously described (Diamond et al., 1990). Briefly,
cells at -50-60% confluency weretransfected with 6 /+g eachof CDll and
CD18 cDNA by the DEAF-Dextran method for 4 h at 37°C (Kingston,
1987). 72 h after transfection, cells were removed from tissue culture plates
with PBS containing 5 mM EDTA and plated onto 13-mm round coverslips
in 24-well plates overnight. Cells were assayed the following day, 4 d after
transfection. Flow cytometry showed that -40-60% of LFA-1-transfected
cells were positive for LFA-1 expression, and that 30-40% of Mac-l-trans-
fected cells were positive for the expression of Mac-1.
Flow Cytometry
Indirect immunofluorescence and flow cytometry were performed as previ-
ously described (Diamond et al., 1990).
SDS-PAGE
Protein samples were analyzed on reducing (5 % ß-mercaptoethanol)
SDS-5% polyacrylamide gels (Laemmli, 1970) and silver stained as de-
scribed (Diamond et al., 1990).
Results
Leishmania Promastigotes Bindto Human
Monocyte-derived Macrophages
Increasing concentrations of radiolabeled L. major pro-
mastigotes were added to human monocyte-derived macro-
phages taken from three donors in either the presence or ab-
51 2sence of 5% fresh human C8-deficient serum (C8D) . A
parasite dose-response curve (Fig . 1 A) shows that promasti-
gotes bind to these cells more efficiently in the presence of
serum than in its absence . At the highest parasite input
concentration (2 .5 x 10 6 ), which in this experiment corre-
sponds to a parasite/macrophage ratio of50:1, macrophages
in the presence of serum bound an average of between two
and three parasites per cell . In the absence of serum at this
dose, these macrophages bound <0.5 parasites per cell . The
three donors depicted in Fig . 1 were representative of a total
of six donors examined . Five of the six donors showed a
comparable lack of binding in the absence of serum at all
doses tested, and at least a fivefold increase in binding in the
presence of serum. A single donor showed greater (approxi-
mately twofold) serum-independent binding relative to the
other donors tested in parallel . The low binding ofL. major
to human macrophages in the absence of exogenous comple-
ment was not improved by pretreating the monolayer with
agents that activate Mac-1, including either 0.2 Ag/ml PMA
(data not shown) or 10 pM ATP (Altieri and Edgington,
1988) (Fig . 1 A) . The inefficient binding in the absence of
serum confirms and extends a previous observation (DaSilva
et al ., 1989), and establishes that the parasites used in this
study were in the infective stage.
Most of the serum-dependent binding of promastigotes to
human macrophages was inhibited by mAbs to Mac-1, but
not by antibodies to either of the other two leukocyte inte-
grins (Fig . 1 B) . OKM1, a Mac-1 a chain-specific mAb,
inhibited binding by -50% . The ß chain-specific antibody
60.3 inhibited binding by 75 %, and a combination of either
two Mac-1 a chain antibodies (LPM19C and OKMI) or an
a and a ß (OKMI and 60.3) inhibited binding by >80% .
Antibodies to either LFA-1 (TSI/22) or p150,95 (SHCL3) in-
hibited binding by <15% . An antibody to CRI, YZ.1, also
had little inhibitory effect in this system (data not shown) .
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PROMASTIGOTESADDED (x10-6 )
￿
PROMASnGOTE BINDING (% Control)
Figure 1. The binding ofradiolabeledL. majorpromastigotes to human monocyte-derivedmacrophages . (A) Dose-responsecurve ofL. ma-
jor binding to human macrophages. Increasing concentrations of leishmania promastigotes were added to 24-well plates containing N5 x
10° macrophages per well . In this representative experiment (of six donors, each analyzed twice), cells from three different donors (o,
0, and t,) were incubated with promastigotes in either the presence (closed symbols) or absence (open symbols) of 5% fresh autologous
serum . Standard deviations are shown if they are larger than symbols . Macrophages from one individual (T) were pretreated for 15 min
with 10 /1MATP before the addition of2 .5 x 106 promastigotes under serum-free conditions . (B) The inhibition ofpromastigote binding
to human macrophages by mAbs to Mac-1 . Monocyte-derived macrophages were preincubated with either a 1:100 dilution of ascites
(LPM19C, 904, TSl/22) or 10 fcg/ml purified antibody (60.3, SHCL3, OKMI, 134) for 20 min at 35°C . A total of 2 x 106 radiolabeled
promastigotes were then added for 60 min at 35°C . Counts per minute were determined in triplicate and compared to simultaneous control
counts per minute (no antibody) . Results reported here are the mean percent of at least two experiments done in triplicate.
Leishmania Promastigotes Adhere Only to
ImmobilizedMac-1
Purified leukocyte integrins were isolated by immunoaffinity
chromatography and immobilized on plastic . The three inte-
grins studied contain a common M 95,000 ß chain which
noncovalently associates with three a subunits of 177,000,
165,000, and 150,000 M, (CDlla-c) (Fig . 2) . Slight differ-
Figure 2. Silver-stained SDS-
PAGE of affinity-purified leu-
kocyte integrins . PurifiedLFA1
(15 11) from a TS2/4 mAb af-
finity column, purified Mac-1
(15 jl) from an LM2/1 mAb
affinity column, and purified
p150,95 (10 j1) from a CBR-
p150/4G1mAb affinitycolumn
(lanes 1, 2, and 3, respec-
tively), were subjected to re-
duction, SDS-5% PAGE and
silver staining . Molecular
weight standards are marked
to left .O
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Figure 3 . The binding of leishmania promastigotes in 5% serum to plates coated with purified human leukocyte integrins . A total of 2
x 106 radiolabeled (A) L. majoror (B) L. amazonensis promastigotes were added to 96-well plates coated with purified Mac-1, p150,95
or LFA-1 as described in Materials and Methods. After washing the average cpm/well f SD of triplicate determinations (left axis) and
the deduced average number oforganisms/well (right axis) were determined . The data shown here forL. major are representative of three
separate experiments, and that for L . amazonensis are representative of two experiments .
ences in the relative migration of the R chains shown in this
silver-stained SDS-polyacrylamide gel occur because differ-
ential subunit association affects the site-specific glycosyla-
tion of thecommonR chain(Dahms and Hart, 1986) . These
isolated receptors retain their immunologic epitopes and
functional activity. The receptors when adsorbed to plastic
retain an active conformation as they bind their respective
ligands, including iC3b, ICAM-1, and ICAM-2 (Dustin and
Springer, 1989 ; Diamond et al ., 1989 ; de Fougerolles et al .,
1991), without any addition of exogenous stimuli . They also
bind mAbs against activation-specific neoepitopes (Diamond,
M . S ., and T . A . Springer, unpublished observations) .
Binding of promastigotes in 5% serum occurred to a
significant level with Mac-l-coated substrates (Figs . 3 and
4) . The parasites did not bind efficiently to either p150,95 or
LFA-1, even though integrin site densities used were able to
sustain stimulated endothelial cell adhesion when tested in
parallel (data not shown) . The binding of parasites to
purified Mac-1 was strong, as 20% of the input ofL. major
adhered to Mac-l, whereas 2-5% bound to p150,95 and 1
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attached to LEA-1 or the controlBSA . At themaximum para-
site input (2 x 106 parasites/well) the total number of or-
ganisms bound to Mac-1 plates in four independent assays
was 4.6 x 105 t 3.5 x 10° organisms per well, forming a
near-confluent lawn of parasites which adhere to the Mac-1
substrate despite the high shear forces created by the washing
procedure (Fig . 4) . This pattern ofMac-l-dependent binding
was reproduced in a second leishmania species, L. amazo-
nensis (Fig . 3 B) .
In the presence of serum, leishmania bind to plates coated
with Mac-1 in a parasite dose-dependent manner (Fig. 5 A) .
In this experiment between 20 and 25% of the total orga-
nisms added to the plates at each dose remained adherent to
the wells after washing . Under serum-dependent conditions
in four independent assays, the percentage of the parasite in-
put which adhered to Mac-1 plates ranged from 12 to 26%,
with a mean of 20% . In the absence of serum, the number
ofparasites bound to the Mac-l-coated substrate was similar
to that bound to BSAcoated plates .
Parasite binding to Mac-1 plates was also dependent on the
Figure 4 . Photomicrograph of L. major promastigotes bound to Mac-l-coated plates . A total of 2.5 x 106 radiolabeled leishmania were
added to purified Mac-1- orLFA1-coated plates in the presence of5% serum for 60 min at 35°C . This inverted micrograph shows viable
promastigotes adhered tightly to a Mac-1 plate (A) but not to LFA-1 (B) after extensive washing .A.
PROMASTIGOTES ADDED (x10-5)
￿
MAC-1 CONCENTRATION (reciprocal dilution)
Figure 5. The binding of L. majorpromastigotes to purified Mac-l-coated plates. (A) Increasingconcentrations of radiolabeled leishmania
in the presence (o) or absence (o) of5 % C8D were added for 1 h at 35°C to 96-well plates coated with Mac-1. These data are representa-
tive oftwo experiments. Data points represent the average of triplicate determinations f SD which are shown only when larger than the
symbols. In this experiment leishmania incorporated 0.012 cpm/organism, thus the maximal binding of 5,771 cpm equals a total of 4.8
x 105 1eishmania bound per well. Backgroundbinding of leishmania to parallel BSA-coated wells, which was 91 cpm at the highest para-
site input dose (o), was not subtracted from any of the values. (B) The binding ofleishmania promastigotes to plates coated with decreas-
ing amounts of human Mac-1. A constant amount of radiolabeled L. majorpromastigotes (2 x 106) was added to plates coated with in-
creasing dilutions of purified Mac-1 antigen. Mac-1 was diluted from 1:12 to 1:30 in 50 mM Tris, 150 mM NaCl, 2 mM MgCl, which
corresponds to a ten-fold range of Mac-1 site densities. A 1:12 dilution of Mac-1 was previouslydetermined to give maximal parasite bind-
ing. The binding of leishmania to control wells coated with BSA is included (T).
quantity ofthe Mac-1 substrate. A constant amount (2 x 106)
of leishmaniawere added to plates, with increasing dilutions
of Mac-1 immobilized to plastic wells (Fig. 5 B). Over a
range of Mac-1 dilutions, parasite binding decreased from a
maximum of2.3 x 105 parasites/well to levels indistinguish-
able from background (Fig. 5 B) .
Adhesion ofLeishmania to Mac4 Plates Requires
OpsonicComplement
Mosser et al. Leishmania Require Complement to Bind to Mac-1
The binding of promastigotes to Mac-1 plates is dependent
on serum complement. Threedifferent species ofleishmania-
L. major, L. amazonensis, and L. donovani-were added to
Mac-1 plates either in the presence of C8D, in the presence
of heat-inactivated C8D (56°C, 60 min), or in the absence
of serum. All the species tested bound to Mac-1 plates only
when fresh serum containing opsonic complement was pres-
ent (Fig. 6, A-C). In the case ofL. major, either heat inacti-
vation of serum or immunologic depletion of C3 from serum
decreased binding from peak levels (10,259 cpm) to back-
ground (289 and 364 cpm, respectively). Furthermore, pre-
treatment of serum with agents that are known to biochem-
ically inactivate C3 or prevent C3 deposition inhibited
parasite binding to Mac-1 by >80% (Table I). The same
trend was observed with the other two species tested as well .
The binding of L. amazonensis to Mac-1 in the presence of
5 % C3-depleted serum (OD) was 661 f 206 cpm. The ad-
dition of 250 p.g/ml of purified 0 to this serum (Quidel,
San Diego, CA) partially restored binding to 3,692 f 1114
cpm (Fig. 6 B) . In a separate experiment, the addition of
purified C3 to OD partially restored binding of L. major
from 472 f 76 cpm to 1,509 f 346 cpm.
The Binding ofPromastigotes to M"-1 Substrates Is
SpecificandInhibitedby mAbs
Promastigotes were added to Mac-1 plates which had been
B .
preincubated for 20 min with various mAbs (Fig. 7) . Two
mAbs to Mac-1, LPM19C and 14B6E.2, each inhibited bind-
ing by >80 %, while a third mAb, LM2/1, inhibited binding
by <30% . OKMI inhibited binding by 53 % . A combination
of OKMI and LPM19C inhibited binding to levels indistin-
guishable from background. An isotype matched antibody
R6.5, against a control antigen, ICAM-1, failed to inhibit
parasite binding. Interestingly, two n Abs (904 and IB4)
which have been reported to inhibit LPG binding to Mac-1
but not affect iC3b binding to Mac-1, had little, ifany, effect
in our binding assay.
Leishmania LPGDoes Not Directly Competefor
Mac-1 Binding
Because other groups report a role of leishmaniaLPG in the
binding of leishmania to macrophages (Thlamus-Rohana,
1990; Handman and Goding, 1985), we studied its role in
our defined system. LPG from L. major promastigotes (100
14g/ml) was preincubated with Mac-l-coated plates for 15
min before the addition of increasing concentrations of
preopsonized leishmania. LPG did not inhibit parasite bind-
ing. Leishmania bound to LPG-treated Mac-1 plates as well
as they bound to control plates (Fig. 8 A). However, if leish-
mania were incubated simultaneously with LPG and com-
plement at the time of opsonization, LPG partially inhibited
the binding of parasites to Mac-1 in a dose-dependent man-
ner (Fig. 8 B). This inhibitory effect was overcome by the
addition of excess (20%) serum. In this system, LPG in-
hibited the binding of leishmaniato Mac-1 only when added
together with complement, presumably by competing with
parasites for complement deposition.
Promastigote Binding to COS CellsExpressing
Cloned Leukocyte Integrins
While the adhesion assays of leishmania promastigotes to
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purified leukocyte integrins strongly suggested an interac-
tion with Mac-1, we wanted to confirm this in a cellular sys-
tem. To achieve expression of only a single leukocyte inte-
grin, COS cells were cotransfected with cDNAs for the
common ß subunit and either the Mac-1 or LFA-1 « subunit.
These cells were used in a leishmaniapromastigote-binding
assay 4 d after transfection. At this time surface expression
of LFA-1 ranged from 40 to 60%, while the expression of
Mac-1 ranged from 30 to 40%, as determined by flow cytom-
etry (data not shown; Diamond et al., 1990) . A range of
leishmania doses was added to these cells in either the pres-
ence or absence of exogenous complement.
COS cells transfected with Mac-1 showed greater binding
of parasites than did mock-transfected cells (Fig. 9). In con-
trast, the binding ofL. major to LFA-1-transfected COS cells
was similar to that ofL. major to mock-transfected cells. The
increased binding of leishmania to Mac-l-expressing COS
cells, as in the purified protein experiments, required the
presence of serum. This increase in parasite binding was
specific to Mac-1, as an antibody to Mac-1 but not to LFA-1
inhibited binding to levels obtained without serum. Micro-
scopic observation (Fig. 10) reveals that between 30 and
40% of the cells bound larger numbers of parasites (>10),
whereas the remaining cellsbound only 1-2 organisms. This
fraction of the cells which sustain strong parasite binding
correlates well with the profile of Mac-1 expression seen by
flow cytometry and suggests that cells expressing high
amounts of Mac-1 bind significantly greater numbers of
parasites than do transfected cells which do not express
significant levels of Mac-1.
516
Discussion
Figure 6. The binding of (A) L. major, (B) L. amazonensis, or (C) L.
donovani promastigotes to purified Mac-l-coated plates. Organisms were
incubated in the presence of C8D, in heat-inactivated normal human se-
rum (H.L ), in the absence of serum (S.L ), in C3D, or in C3D with
purified C3 added back to it (C3D+C3). The mean cpm's boundper well
f SD oftriplicate determinations (left axis) and the average total number
of organisms bound per well deduced from these cpm's (right axis) is in-
cluded for each species.
Leishmania are obligate intracellular parasites that reside al-
most exclusively within mononuclear phagocytes (Chang,
1983). Several groups have examined the molecular basis for
the binding and internalization of promastigotes by macro-
phages in vitro and have demonstrated that specific macro-
phage phagocytic receptors mediate this interaction (Mosser
and Edelson, 1984b; DaSilva et al., 1989; Blackwell et al.,
1985 ; Wilson and Pearson, 1988; Chang, 1983; Tàlamus-
Rohana et al., 1990). Previous studies have shown that leish-
mania are able to fix complement directly from nonimmune
Table L The Binding ofRadiolabeled
Leishmania to Mac-] Plates after Incubations
in Serum Depleted of C3
" C8D was pretreated for 30 min at 35°C with 5 U/ml cobra venom factor, 0.2
M potassium thiocyanate, 0.2 M hydroxylamine, or 15 mM EDTA.
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washing t standard deviation of triplicate samples.
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serum (Mosser and Edelson, 1984b; Puentes et al., 1988),
and that this enhances entry into (Mosser and Edelson,
1985) and survival within macrophages (Mosser and Edel-
son, 1987). This increased entry requires complement and
is greatly reduced by mAbs to CD11b (Blackwell et al .,
1985; Mosser and Edelson, 1985). Interestingly, several
groups have reported that leishmaniabind directly to macro-
phage receptors in the absence of serum or exogenous com-
plement, and that this interaction is also inhibited by mAbs
to Mac-1 (Blackwell et al., 1985; Mosser and Edelson,
1985; Russel and Wright, 1988; Tàlamus-Rohana et al.,
1990; Cooper et al., 1988) . Some of these groups (Russell
and Wright, 1988; Talamus-Rohana et al ., 1990) suggest that
leishmania surface molecules may bind directly to Mac-1
and perhaps the other leukocyte integrins. A potential criti-
cism ofthese experiments is that even in the absence ofexog-
enous serum, macrophages may produce enough endoge-
nous C3 to facilitate a complement-dependent parasite
binding (Wozencraft et al ., 1986). Thus, it is still difficult to
discern whether leishmaniabinding to macrophages through
the leukocyte integrins requires complement.
To address this question, we developed an assay for leish-
mania binding in which the presence ofopsonic complement
couldbe rigorously controlled. Parasites were preincubated
in the presence or absence ofcomplementand allowed to ad-
here to both transfected fibroblasts expressing members of
the leukocyte integrin family (Mac-1 and LFA-1) or to im-
Figure 8. The effectofpurified
leishmania LPG on the bind-
ing ofL. majorpromastigotes
to Mac-1 plates. (A) Increas-
ing concentrations of preop-
sonized leishmania promasti-
gotes were added to Mac-1
plateswhich had been pretreat-
ed for 15 min with 100 itg/ml
purified LPG (9) or saline
(o). The LPG was left in the
wells during the incubation
with leishmania. (B) A total
x 107 promastigotes were incubated in 5% C8D serum and increasing concentrations (0-500 ug/ml) of leishmania LPG for 15 min .
A constant amount of unwashed promastigotes (2 x 106) was added to untreated Mac-1 plates in triplicate (o). The binding of an equal
number of parasites incubated in 20% C8D and 500 Ag/ml LPG is included (*).
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munoaffinity-purified leukocyte integrin substrates (Mac-1,
LFA-1, and p150,95) . Our results suggest that leishmania
promastigotes require opsonic complement to bind to the
leukocyte integrins. Furthermore, we find that opsonized
leishmania bind predominantly to the Mac-1 integrin . They
do not bind appreciably to LFA-1 and bind only weakly to
p150,95.
Our evidence for these conclusions is as follows: (a) Two
species of leishmania (L. major and L. amazonensis) bound
strongly to purified Mac-1 substrates but not to those con-
taining LFA-1 or control proteins. Binding to purified
p150,95 was reproducibly weaker, but was partially inhibited
by specific mAb (data not shown). All three purified recep-
tors retain their antigenicity and biological function (Dustin
and Springer, 1989; Diamond et al., 1990; Stacker and
Springer, 1991), and the site densities used in this study were
sufficientto sustain endothelial cell binding (data not shown) .
(b) The binding to Mac-1 was dose-dependent both for the
concentration ofparasites and Mac-1. It was also specific be-
cause it was inhibited strongly by some but not all mAbs to
Mac-1. (c) L. major showed an enhanced ability to bind to
COS cellsexpressing Mac-1, but not to LFA-1 or mock-trans-
fected cells. This increase was abolished by mAbs to Mac-1.
The low-level background binding of promastigotes to un-
transfected and LFA-1-transfected COS cells presumably
occurred by a serum-independent mechanism which may
be mediated via lectin-like receptors on mammalian cells
Figure 7 . The inhibitionofL. majorpromasti-
gote binding to Mac-1 substrates. Mac-1 sub-
strates were incubated with mAbs for 20 min
before and during the addition of 2 x 106
leishmania in 5% C8D for 60 min at 35°C.
Antibodies LPM19C, 904, and 14136E.2
were used as ascites diluted 1:100. Antibodies
R6.5, IB4, LM2/1, and OKMI were used as
purified IgG at a final concentration of 10
Ag/ml. R6.5 mAb to ICAM-1 was used as a
nonbinding control antibody. Counts per
minute were determined in triplicate and
compared to simultaneous control counts per
minute (no antibody) . Results reported here
are the mean percent control of at least two
experiments done in triplicate.X v
J
W v
n.
U
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Figure 9 The binding of radiolabeled L. major promastigotes to
transfected COS cells . Increasing concentrations ofpromastigotes
were added toCOS cells transfected with Mac-1 (0,e), with LFA-1
(e,A), or with plasmid alone (o,m) in the presence (closed sym-
bols) or absence (open symbols) of 5% C8D. Binding of promasti-
gotes in serum to Mac-1 substrates in the presence of antibody to
Mac-1 (LPM19C) (v) or to LFA1 (TSl/22) (v) is included . Data
points represent the mean (triplicates) cpm/well f SD (left axis)
and the deduced number of parasites per cell .
(Blackwell et al., 1985 ; Wilson and Pearson, 1988) recog-
nizing LPGs on leishmania (Bouvier et al ., 1985 ; Handman
and Goding, 1985) . (d) The binding of leishmania to
purified Mac-1 or to COS cells expressing Mac-1 required
the presence ofcomplement, since incubation in the absence
of serum, in the presence of heat-inactivated serum, or with
serum immunologically or biochemically depleted of C3
eliminates binding . The addition of C3 to depleted serum
partially restored binding to purified Mac-1 . Failure to com-
pletely restore binding was due to complement-mediated ly-
sis ofpromastigotes afterC3 addition, as the C3-deficient se-
rum used contains all the terminal components of the
complement cascade . Lysed promastigotes release radio-
label (Mosser and Edelson, 1984), which was removed by
washing . (e) These experiments with transfected and purified
Mac-1 agree with data from human macrophages, as the
presence of active complement greatly enhances binding of
parasites, and this increase was inhibited almost completely
by blocking mAbs to Mac-1, and not to LFA-1 or p150,95.
Interestingly, in our system, the complement receptor type 1
(CRI .) apparently has only a minor role in promastigote bind-
ing . Monoclonal antibodies to the CR3 (OKMI and LMP-
19c) block the majority ofparasite binding tohuman macro-
phages, whereas mAbs to the CRl block poorly, if at all .
The requirement for opsonic complement for leishmania
binding to Mac-1 suggests that the interaction between para-
site and macrophage may be mediated by Mac-1 binding to
iC3b, a well-characterized adhesive interaction that is criti-
cal to immune clearance of foreign particles (Beller et al.,
1982 ; Wright et al., 1983) . The mAbs to Mac-1 which in-
hibit leishmania binding are the same as those which block
iC3b binding to cellular or purified Mac-1 (Diamond et al.,
1989 ; Garcia-Aguilar, J .,M . S . Diamond, andT.A . Springer,
manuscript in preparation) : LPM19c and 14B6E.2 block
strongly, OKM1 inhibits partially, and LM2/1 blocks only
weakly the binding of leishmania to Mac-1 . Parasites which
bind to intact macrophages without a requirement for exog-
enous complement may be able to fix the small amount of
C3 that is generated endogenously by macrophages . In con-
trast, others have demonstrated that beads coated with iso-
lated leishmania molecules bound to neutrophils in the ab-
sence of complement (Talamus-Rohana et al ., 1990) . This
binding was inhibited by twomAbs (904 and IB4) that react
with Mac-1 at sites distinct from the iC3b binding site . We
believe that this serum-independent binding represents a mi-
nor contribution, because when we use intact viable para-
sites, these two antibodies have little effect on binding to
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Figure 10. Photomicrograph show-
ing the binding ofL . majorpromasti-
gotes toCOS cells expressing Mac-1 .
A total of 2.5 x 106 leishmania
were added to 24-well plates contain-
ing N5 x 10° COS cells in the pres-
enceof5 % C8D. Numerous promas-
tigotes bound to the periphery of
some cells are indicated by arrows .Mac-1. The fixation of complement by the two leishmania
surface structures gp63 and LPG may explain in part why
other groups have observed a role for these structures in the
binding of leishmania to macrophages (Talamus-Rohana et
al., 1990; Russell and Wright, 1988) . In our experiments,
the inhibition ofleishmaniabinding to Mac-1 by LPGdid not
occur unless LPG was coincubated with parasites and com-
plement. This inhibitory effect occurred at relatively high
LPG concentrations and was overcome by the addition ofex-
cess serum. Thus, we believe that the inhibitory role of
soluble LPG in our system is due, at least in part, to its abil-
ity to fix and consume complement.
Using purified proteins and transfected cells, we have ex-
amined the interaction ofleishmaniawith individual cell sur-
face receptors and conclude that there is a requirement for
opsonic complement for parasite interaction with Mac-1. It
is interesting that several other microorganisms have been
observed to bind to Mac-1 including E. coli (Wright and
Jong, 1986), B. pertussis (Relman et al., 1990), and H. cap-
sulatum (Bullock and Wright, 1987). These studies were
performed usingmacrophages as the source ofMac-1. It will
be interesting to determine whether these organisms bind
directly to Mac-1 or, in a manner similar to leishmania, re-
quire opsonic complement to allow adhesion. We hypothe-
size that many intracellular microbes may subvert the well-
characterized Mac-1-iC3b phagocytosis pathway to initiate
cellular infections.
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